EP Patent

EP4480956A2 — Viral inhibitors, the synthesis thereof, and intermediates thereto

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2024-12-25 · 1y expired

What this patent protects

The present disclosure discloses compositions comprising maribavir, methods of providing the same, and compositions providing intermediates useful in providing maribavir.

USPTO Abstract

The present disclosure discloses compositions comprising maribavir, methods of providing the same, and compositions providing intermediates useful in providing maribavir.

Drugs covered by this patent

Patent Metadata

Patent number
EP4480956A2
Jurisdiction
EP
Classification
—
Expires
2024-12-25
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.